Sepantronium
- Generic Name
- Sepantronium
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H19N4O3
- CAS Number
- 753440-91-4
- Unique Ingredient Identifier
- UZ77T1VFBM
- Background
Sepantronium is a compound that suppresses survivin expression in a dose and time-dependent manner, and causes broad-range apoptosis.
- Associated Conditions
- -
- Associated Therapies
- -
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
Phase 1
Completed
- Conditions
- NSCLCSolid Tumors
- Interventions
- First Posted Date
- 2010-04-09
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 42
- Registration Number
- NCT01100931
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath